Market Access -

Trending

in News
Pharma fury as Trump’s team reneges on biologic patent rules in trade talks
December 12, 2019 Share
X
Pharma fury as Trump’s team reneges on biologic patent rules in trade talks
https://pharmaphorum.com/news/pharma-fury-as-trumps-team-reneges-on-biologic-patent-rules-in-trade-talks/
in News
UK’s NHS to fund Shionogi’s Mulpleo after backing from NICE and SMC
December 12, 2019 Share
X
UK’s NHS to fund Shionogi’s Mulpleo after backing from NICE and SMC
https://pharmaphorum.com/news/uks-nhs-to-fund-shionogis-mulpleo-after-backing-from-nice-and-smc/

Latest News

Scotland backs AZ’s Lynparza for first-line ovarian cancer maintenance

Scotland backs AZ’s Lynparza for first-line ovarian cancer maintenance

The Scottish Medicines Consortium (SMC) has backed routine funding of AstraZeneca and MSD’s Lynparza as a maintenance treatment

X

Scotland backs AZ’s Lynparza for first-line ovarian cancer maintenance

https://pharmaphorum.com/news/scotland-backs-azs-lynparza-for-first-line-ovarian-cancer-maintenance/

ViiV presses go on FDA filing for first-in-class HIV drug fostemsavir

ViiV presses go on FDA filing for first-in-class HIV drug fostemsavir

ViiV Healthcare has fulfilled its pledge of submitting its new HIV drug fostemsavir for approval before year end,

X

ViiV presses go on FDA filing for first-in-class HIV drug fostemsavir

https://pharmaphorum.com/news/viiv-presses-go-on-fda-filing-for-first-in-class-hiv-drug-fostemsavir/

Amgen strikes outcomes-based payment plan for Enbrel with Abarca

Amgen strikes outcomes-based payment plan for Enbrel with Abarca

Pharmacy benefit manager Abarca has announced a US reimbursement contract with Amgen for its Enbrel (etanercept) inflammatory diseases

X

Amgen strikes outcomes-based payment plan for Enbrel with Abarca

https://pharmaphorum.com/news/amgen-strikes-outcomes-based-payment-plan-for-enbrel-with-abarca/

Views & analysis

15 pharma trends for 2020

15 pharma trends for 2020

Real world evidence, patient centricity and new digital experiences are among the top 15 trends set to change

X

15 pharma trends for 2020

https://pharmaphorum.com/views-analysis-digital/15-pharma-trends-for-2020/

How does prevalence affect pricing of rare disease drugs?

How does prevalence affect pricing of rare disease drugs?

New research from CRA looks at the relationship between rarity of a disease and the price countries are

X

How does prevalence affect pricing of rare disease drugs?

https://pharmaphorum.com/views-analysis-market-access/prevalence-pricing-rare-disease-drugs/

Nine for 2019: how did we do on our predictions, and what does this mean for 2020?

Nine for 2019: how did we do on our predictions, and what does this mean for 2020?

Year-ends prompt reflection, both on what’s happened in the last 12 months and on the year ahead. At

X

Nine for 2019: how did we do on our predictions, and what does this mean for 2020?

https://pharmaphorum.com/views-and-analysis/nine-for-2019-2020/

Debates & Insights

Innovative contracting in Europe – a Trojan horse?

Innovative contracting in Europe – a Trojan horse?

Overview With pricing of drugs at the centre of political and social debate, the market access and pricing

X

Innovative contracting in Europe – a Trojan horse?

https://pharmaphorum.com/market-access-2/innovative-contracting-in-europe-a-trojan-horse/

Launch excellence in a disrupted world – challenges & opportunities

Launch excellence in a disrupted world – challenges & opportunities

Overview The launch environment has undergone huge changes as the pharmaceutical industry’s focus has moved from primary care

X

Launch excellence in a disrupted world – challenges & opportunities

https://pharmaphorum.com/market-access-2/launch-excellence-in-a-disrupted-world-challenges-opportunities/

Orphan medicines launch excellence: sustaining launch success

Orphan medicines launch excellence: sustaining launch success

Overview Launching orphan medicines excellently will become even more important over the next five years as more patients

X

Orphan medicines launch excellence: sustaining launch success

https://pharmaphorum.com/market-access-2/orphan-medicines-launch-excellence-sustaining-launch-success/

Partner Content

Pre-Filled Syringes East Coast 2020

Pre-Filled Syringes East Coast 2020

Pre-Filled Syringes East Coast conference

X

Pre-Filled Syringes East Coast 2020

https://pharmaphorum.com/events/pre-filled-syringes-east-coast-2020/

AI in Drug Discovery Conference 2020

AI in Drug Discovery Conference 2020

AI in Drug Discovery Conference 2020

X

AI in Drug Discovery Conference 2020

https://pharmaphorum.com/events/ai-in-drug-discovery-conference-2020/

Registration is Now Open for Pre-Filled Syringes East Coast Conference

Registration is Now Open for Pre-Filled Syringes East Coast Conference

PFS East Coast Registration now open

X

Registration is Now Open for Pre-Filled Syringes East Coast Conference

https://pharmaphorum.com/partner-content/registration-is-now-open-for-pre-filled-syringes-east-coast-conference/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com